Back

Optimizing antithrombotic therapy after PFO closure: insights from real-world practice

29 August 2026 (10:15 - 10:40)
Organised by: Logo
Congress Presentation Part of: Stroke risk and the heart: patent foramen ovale and other risks Patent Foramen Ovale and Patent Foramen Ovale (PFO) Closure ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Miss Amalia Papanikolaou

University of Duisburg-Essen - West-German Heart and Vascular Centre, Essen (Germany)

2 More presentations in this session

Presentation thumbnail
Anatomical and functional predictors of uncrossable PFO in patients with cryptogenic stroke
Professor W. Kang (KR)
Abstract Slides Video
Presentation thumbnail
β3-adrenergic receptor activation exacerbates brain injury in acute ischemic stroke
Miss K. Cheung (Zurich, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Stroke risk and the heart: patent foramen ovale and other risks

The Event

Event poster

ESC Congress 2026

29 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Advances in PFO management: closure vs anticoagulation.
29 August 2022
thumbnail
Congress Presentation
Risk of early device-related thrombosis in post-Watchman cases on low-dose oral-anticoagulation versus dual-antiplatelet therapy
14 April 2026
thumbnail
Congress Presentation
Oral anticoagulation after catheter ablation: does continuation or discontinuation affect major cardiovascular outcomes? a systematic review and meta-analysis of 143,855 patients
28 August 2026
thumbnail
Congress Presentation
Device-related thrombus after percutaneous intervention for Atrial Septal Defect (ASD) and Patent Foramen Ovale (PFO)
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources